Targeting isocitrate lyase for the treatment of latent tuberculosis

RP Bhusal, G Bashiri, BXC Kwai, J Sperry… - Drug Discovery …, 2017 - Elsevier
Highlights•Isocitrate lyase (ICL) is essential to growth and survival of Mycobacterium
tuberculosis (Mtb).•ICL is involved in Mtb glyoxylate and methylisocitrate cycles, and may …

Manipulation and Exploitation Of Host Immune System by Pathogenic Mycobacterium Tuberculosis for its Advantage

MA Mir, B Mir, M Kumawat, M Alkhanani… - Future Microbiology, 2022 - Taylor & Francis
Mycobacterium tuberculosis (Mtb) can become a long-term infection by evading the host
immune response. Coevolution of Mtb with humans has resulted in its ability to hijack the …

Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase

R Shukla, H Shukla, A Sonkar, T Pandey… - Journal of …, 2018 - Taylor & Francis
Mycobacterium tuberculosis is the etiological agent of tuberculosis in humans and is
responsible for more than two million deaths annually. M. tuberculosis isocitrate lyase …

Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility

H Shukla, R Shukla, A Sonkar, T Pandey, T Tripathi - Scientific reports, 2017 - nature.com
Isocitrate lyase (ICL), a potential anti-tubercular drug target, catalyzes the first step of the
glyoxylate shunt. In the present investigation, we studied the conformational flexibility of …

Alterations in conformational topology and interaction dynamics caused by L418A mutation leads to activity loss of Mycobacterium tuberculosis isocitrate lyase

H Shukla, R Shukla, A Sonkar, T Tripathi - Biochemical and biophysical …, 2017 - Elsevier
Mycobacterium tuberculosis isocitrate lyase (MtbICL) is a key enzyme of the glyoxylate cycle
that catalyzes the cleavage of isocitrate to succinate and glyoxylate and is a potential …

Structural and energetic understanding of novel natural inhibitors of Mycobacterium tuberculosis malate synthase

R Shukla, H Shukla, T Tripathi - Journal of Cellular …, 2019 - Wiley Online Library
Persistent infection by Mycobacterium tuberculosis requires the glyoxylate shunt. This is a
bypass to the tricarboxylic acid cycle in which isocitrate lyase (ICL) and malate synthase …

Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site

R Shukla, H Shukla, T Tripathi - Tuberculosis, 2018 - Elsevier
Mycobacterium tuberculosis isocitrate lyase (MtbICL) is a crucial enzyme of the glyoxylate
cycle and is a validated anti-tuberculosis drug target. Structurally distant, non-active site …

Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics

M Zhou, L Xie, Z Yang, J Zhou, J Xie - Journal of Biomolecular …, 2017 - Taylor & Francis
Lysine succinylation (Ksucc) is a newly identified protein posttranslational modification
(PTM), which may play an important role in cellular physiology. However, the role of lysine …

Crystal Structure and Molecular Mechanism of Isocitrate Lyase from Chloroflexus aurantiacus

SH Lee, J Park, KJ Kim - Journal of Agricultural and Food …, 2024 - ACS Publications
Chloroflexus aurantiacus is a green, nonsulfur bacterium that employs the 3-
hydroxypropionate cycle to grow, using carbon dioxide/bicarbonate as its primary carbon …

Impact of protein dynamics on secondary structure prediction

AG de Brevern - Biochimie, 2020 - Elsevier
Protein 3D structures support their biological functions. As the number of protein structures is
negligible in regards to the number of available protein sequences, prediction …